series a
Stage
2020
Founded
1
Investors
About
Enumerix (now Countable Labs) develops Countable PCR, a digital PCR technology delivering ultra-high sensitivity, precision, and multiplexing capabilities for clinical diagnostics, cell and gene therapy, and infectious disease applications.
Explore Enumerix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.